EGFR and cancer: Given that STEAP3 is primarily localized to the plasma membrane and has been shown to interact with epidermal growth factor receptor (EGFR), modulating its nuclear translocation to activate gene expression associated with cancer cell proliferation4, it is plausible that STEAP3 may similarly interact with viral receptors to influence viral binding.